FDA NDC Directory · JSON-LD · Markdown
NDC 65862-697 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE
| Labeler / Manufacturer | Aurobindo Pharma Limited |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA200834 |
| Dosage form / route | CAPSULE, EXTENDED RELEASE · ORAL |
| Active ingredients | VENLAFAXINE HYDROCHLORIDE (150 mg/1) |
| Marketing started | 20111123 |
| Package count | 7 |
Source: openFDA. Public-domain (CC0).